Opendata, web and dolomites

SOLID SIGNED

Suppression of Organelle Defects in Human Disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SOLID project word cloud

Explore the words cloud of the SOLID project. It provides you a very rough idea of what is the project "SOLID" about.

cures    biology    create    difficulty    genetics    hurdles    suppression    recessive    limited    drugging    entirely    exhaustive    mutants    uniquely    remove    ultradeep    alongside    until    therapeutic    genome    model    fixed    genes    cellular    etiological    neurodegeneration    diversity    mapping    fidelity    hundreds    gene    time    strategies    hidden    suppressor    point    malfunctioning    frustrations    extensive    captures    solid    lacking    questions    fitness    amount    paradigm    organelles    engineering    yielding    mutation    revealing    impaired    instead    causative    contain    mutagenesis    concerted    modules    surveys    relies    uncover    stratification    disorders    metabolic    mainly    phenotypes    altogether    correct    initial    suppressors    combines    applicable    cell    first    biological    defects    organelle    eukaryotic    disease    centric    functioning    perturbation    mostly    mitochondria    systematic    substantial    genetic    machines    independent    exemplified    groundbreaking    possibilities    direct    platform    triggers    query    interrogate    alter    departs    perturbed    absent    incurable    human    environmental    reveal    yeast    view    fashion    diseases    haploid    function    organisms    mutations    lysosomes    urgently   

Project "SOLID" data sheet

The following table provides information about the project.

Coordinator
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN 

Organization address
address: GESCHWISTER SCHOLL PLATZ 1
city: MUENCHEN
postcode: 80539
website: www.uni-muenchen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 1˙498˙400 €
 EC max contribution 1˙498˙400 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-STG
 Funding Scheme ERC-STG
 Starting year 2019
 Duration (year-month-day) from 2019-07-01   to  2024-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN DE (MUENCHEN) coordinator 1˙498˙400.00

Map

 Project objective

The goal of SOLID is the systematic mapping of genetic suppression for important organelles with impaired fidelity in human disease to uncover new strategies to correct the perturbed state. Functioning of the eukaryotic cell relies on the concerted activity of biological machines, defects in which can cause incurable human disease, including metabolic disorders and neurodegeneration. This is exemplified by malfunctioning mitochondria or lysosomes, for which (alongside environmental triggers) hundreds of causative genes have been identified, but cures are mostly lacking. This is mainly due to the difficulty of drugging loss-of-function mutations, which uniquely alter or entirely remove the gene product. Extensive studies in yeast and initial work in the human system show that cellular modules contain a substantial amount of hidden genetic suppression. Revealing suppressors of disease-defining features of organelle perturbation and targeting those instead of the query mutations, will address the frustrations of drugging an absent factor and etiological diversity. Until now, mutation-based genome-wide suppressor surveys were mostly limited to model organisms and phenotypes yielding growth defects, due to technical hurdles associated with recessive genetics in the human system. However, with the development of a groundbreaking new forward genetics platform that combines genome engineering, ultradeep haploid mutagenesis and direct stratification of fixed mutants, we can now, for the first time, interrogate genetic suppression of human organelle defects independent of cellular fitness. SOLID will also develop new technology to study organelle fidelity in an exhaustive fashion that departs from a gene-centric view point and captures complex phenotypes. Altogether, this will create a new paradigm of 'studying cell biology via genetics' widely applicable to many different biological questions, and reveal urgently needed novel therapeutic possibilities for incurable diseases.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SOLID" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SOLID" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

OAlipotherapy (2018)

Long-retention liposomic drug-delivery for intra-articular osteoarthritis therapy

Read More  

QUAMAP (2019)

Quasiconformal Methods in Analysis and Applications

Read More  

CoolNanoDrop (2019)

Self-Emulsification Route to NanoEmulsions by Cooling of Industrially Relevant Compounds

Read More